IRS2 and colorectal carcinoma: Somatic mutations of phosphatidylinositol 3-kinase (PI3KCA) are found in ~30% of CRC and encompass the loss of PTEN, and the amplification of insulin receptor substrate 2 (IRS2), AKT, and PAK4 [17].